Freestone Grove Partners LP purchased a new stake in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 43,337 shares of the company's stock, valued at approximately $299,000. Freestone Grove Partners LP owned about 0.09% of Nu Skin Enterprises as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Franklin Resources Inc. grew its stake in shares of Nu Skin Enterprises by 6.5% during the fourth quarter. Franklin Resources Inc. now owns 34,307 shares of the company's stock worth $236,000 after purchasing an additional 2,091 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in Nu Skin Enterprises by 5.3% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 53,711 shares of the company's stock worth $371,000 after buying an additional 2,702 shares during the last quarter. Russell Investments Group Ltd. boosted its position in shares of Nu Skin Enterprises by 29.5% during the 4th quarter. Russell Investments Group Ltd. now owns 12,146 shares of the company's stock worth $83,000 after acquiring an additional 2,768 shares in the last quarter. Ballentine Partners LLC increased its holdings in shares of Nu Skin Enterprises by 15.5% in the 4th quarter. Ballentine Partners LLC now owns 20,856 shares of the company's stock valued at $144,000 after acquiring an additional 2,800 shares during the last quarter. Finally, Meeder Asset Management Inc. acquired a new stake in shares of Nu Skin Enterprises during the 4th quarter worth about $25,000. 82.84% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, StockNews.com lowered shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research note on Tuesday, April 8th.
Read Our Latest Analysis on NUS
Nu Skin Enterprises Stock Performance
Shares of NYSE NUS traded up $0.67 during trading hours on Friday, reaching $6.83. The stock had a trading volume of 1,168,511 shares, compared to its average volume of 836,971. The firm has a 50-day moving average of $6.73 and a 200-day moving average of $6.94. The firm has a market cap of $339.61 million, a price-to-earnings ratio of -2.32 and a beta of 0.92. The company has a current ratio of 1.82, a quick ratio of 1.17 and a debt-to-equity ratio of 0.56. Nu Skin Enterprises, Inc. has a fifty-two week low of $5.32 and a fifty-two week high of $14.00.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.15 by $0.08. The business had revenue of $364.49 million for the quarter, compared to analyst estimates of $352.06 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. Equities research analysts predict that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.
Nu Skin Enterprises Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 11th. Shareholders of record on Friday, May 30th will be paid a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a yield of 3.51%. The ex-dividend date of this dividend is Friday, May 30th. Nu Skin Enterprises's dividend payout ratio is presently -8.14%.
Nu Skin Enterprises Company Profile
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Further Reading

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.